Capstone Investment Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Capstone Investment Advisors, LLC
- $38.9 Billion
- Q4 2024
A detailed history of Capstone Investment Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 500 shares of CRL stock, worth $75,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 200
150.0%
Holding current value
$75,260
Previous $39,000
135.9%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$927 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$766 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$328 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$272 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$272 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.66B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...